| |
 |
Patricia
J. Keely, Ph.D.
Associate
Professor
Department of Pharmacology
|
Trainer in the
Following Programs:
- Molecular and Cellular
Pharmacology Program
- Cell and Molecular Biology
Program
|
- Awards:
- 2001 - Shaw Scientist Award
- Susan G. Komen-AACR Career
Development Award
- Howard Hughes Medical Institute
Start-up Award
- NIH FIRST award
- NIH National Research Service
Award Postdoctoral Fellowship
- Lucille P. Markey Postdoctoral
Fellowship
- March of Dimes Postdoctoral
and Predoctoral Fellowships
- Bacanar Research Award
|
Appropriate cellular interactions
with the extracellular matrix (ECM) help to establish normal cellular
architecture and differentiation. During oncogenic transformation, these
normal interactions with the ECM are profoundly altered, resulting in
cells that lose their polarization and differentiation, lose anchorage
dependent growth control, and acquire a migratory, invasive phenotype.
Our lab is interested in understanding, at a molecular level, how cellular
interactions with the ECM determine differentiation and epithelial polarization,
and how these interactions are altered during carcinogenesis to result
in invasive, metastatic carcinoma.
Understanding molecular mechanisms underlying breast cancer risk due
to breast density
Patients with dense
breast tissue have a four to six-fold increased risk of developing breast
carcinomas. In fact, 1/3 of all breast cancer cases are attributed
to breast density, making it one of the greatest risk factors for carcinoma.
Increased breast density is associated with a significant increase in
the deposition of connective tissue, or extracellular matrix (ECM) components,
most notably the protein, collagen. We have been developing model
systems to understand why increased breast density results in an increased
risk for developing breast carcinoma. We find in a simple in vitro model
that increasing the density of collagen in the matrix is sufficient to
disrupt breast epithelial differentiation, suggesting that matrix density
is itself an important regulator of cellular behavior. Additionally,
we are employing a mouse strain engineered to have more collagen in its
connective tissue. Mouse tumor studies are underway to directly
test whether increased collagen density will enhance tumor formation or
tumor metastasis.
|
|
| Mammary
epithelial cells cultured in 3D collagen gels differentiate
into tubule structures. This differentiation is disrupted
when cells are cultured in dense 3D collagen gels, providing
a model system for understanding the molecular underpinnings
for cellularresponses to matrix density |
|
State of the art imaging
approaches are being used to characterize the collagen structure
in normal glands and around tumors so that we can better understand
the physical relationship between cells and the collagen fibers
found in breast tissue. We find evidence for a collagen signature
that is present in even before a tumor is palpable, predicting where
a tumor will soon arise. We are investigating whether this
signature can be developed as a tool to aid in diagnosing human
breast carcinoma at an earlier stage.
Using biochemical and
DNA microarray approaches, we are characterizing several biochemical
and genetic changes that occur in cells that encounter dense matrices.
Dense collagen environments activate signal pathways within cells
that result in a more tumor-like behavior: increased cell proliferation
or growth, decreased cell death, and increased ability to invade
into nearby tissues. We expect that our studies to characterize
the molecular response of cells to dense collagen matrices will
allow us to better understand tumor progression. |
 |
Mouse mammary carcinoma
cells (blue) invading into the surrounding collagen stroma (green/yellow)
in fresh, unstained, unfixed tissue, and visualized by Fluorescent
Lifetime Imaging Microscopy |
Molecular signaling events
related to cell interactions with the ECM
Cells interact with the ECM
through a variety of cell surface receptors, the best understood of which
are members of the integrin family. Much remains to be determined regarding
the specific molecular players and signaling pathways downstream of integrins,
and how these pathways are involved in the progression of various diseases.
Therefore, part of the focus of the lab is to investigate signaling events
through the integrin family of receptors. A second aspect of this work
is to investigate how small GTPases of the Ras superfamily, some of which
are known or suspected oncogenes, affect the response of cells to the
ECM. Specifically, we have focused on R-Ras and Rho, which we find alter
the way breast epithelial cells respond to the ECM, promoting cellular
migration and invasion. We are particularly interested in studying signaling events using state
of the art imaging approaches to understand how small GTPases function
in a spatial and temporal manner during cell migration.
Selected Publications: Articles on PubMed
- Keely PJ, Conklin MW, Gehler S, Ponik SM, and Provenzano PP. (2007). Investigating integrin regulation and signaling events in three-dimensional systems. Methods Enzymol. 426:27-45. PMID 17697878
- Skala MC, Riching KM, Bird DK, Gendron-Fitzpatrick A, Eickhoff J, Eliceiri KW, Keely PJ, and Ramanujam N. (2007). In vivo multiphoton fluorescence lifetime imaging of protein-bound and free nicotinamide adenine dinucleotide in normal and precancerous epithelia. J Biomed Opt. 12:024014. PMID 17477729
- Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, and Keely PJ. (2007). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4:38. PMID 17190588
- Modzelewska K, Newman LP, Desai R, Keely PJ. (2007). Ack1 mediates Cdc42-dependent cell migration and signaling to p130Cas. J Biol Chem. 281:37527-37535. PMID 17038317
View More Publications
|